Page 1 of Clinical Trials for Drug erlotinib hydrochloride, 603 Total Matches
- 1RecruitingLast Updated: November 15, 2011Condition(s): Advanced Cancer
- 2RecruitingLast Updated: December 13, 2011Condition(s): Solid Tumors
- 3Not yet recruitingLast Updated: December 28, 2011Condition(s): Lung Cancer
- 4CompletedLast Updated: August 6, 2009Condition(s): Malignant Brain Tumor; Brain Stem Glioma,
- 5CompletedLast Updated: September 20, 2011Condition(s): Dermatologic Complications; Unspecified Adult Solid Tumor, Protocol Specific
- 6CompletedLast Updated: August 5, 2010Condition(s): Drug/Agent Toxicity by Tissue/Organ; Head and Neck Cancer; Lung Cancer; Ovarian Cancer
- 7RecruitingLast Updated: January 17, 2012Condition(s): Metastatic Non-Small Cell Lung Cancer
- 8Active, not recruitingLast Updated: September 30, 2008Condition(s): Lung Cancer
- 9TerminatedLast Updated: January 20, 2010Condition(s): Cervical Cancer
- 10SuspendedLast Updated: December 5, 2011Condition(s): Ovarian Cancer
- 11Enrolling by invitationLast Updated: December 19, 2011Condition(s): Ependymoma
- 12RecruitingLast Updated: September 20, 2011Condition(s): Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma; Recurrent Metastatic Squamous Neck Cancer With Occult Primary; Recurrent Salivary Gland Cancer; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Squamous Cell Carcinoma of the Nasopharynx; Recurrent Squamous Cell Carcinoma of the Oropharynx; Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Recurrent Verrucous Carcinoma of the Larynx; Recurrent Verrucous Carcinoma of the Oral Cavity; Salivary Gland Squamous Cell Carcinoma; Stage IV Salivary Gland Cancer; Stage IV Squamous Cell Carcinoma of the Hypopharynx; Stage IV Squamous Cell Carcinoma of the Larynx; Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IV Squamous Cell Carcinoma of the Nasopharynx; Stage IV Squamous Cell Carcinoma of the Oropharynx; Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IV Verrucous Carcinoma of the Larynx; Stage IV Verrucous Carcinoma of the Oral Cavity; Tongue Cancer; Untreated Metastatic Squamous Neck Cancer With Occult Primary
- 13RecruitingLast Updated: July 19, 2011Condition(s): Colorectal Cancer
- 14RecruitingLast Updated: November 30, 2011Condition(s): Solid Tumors; Advanced Cancer
- 15CompletedLast Updated: June 30, 2011Condition(s): Carcinoma, Non-Small-Cell Lung
- 16RecruitingLast Updated: January 17, 2012Condition(s): Precancerous Conditions
- 17Active, not recruitingLast Updated: April 10, 2009Condition(s): Lung Cancer
- 18Active, not recruitingLast Updated: November 18, 2009Condition(s): Non Small Cell Lung Cancer
- 19RecruitingLast Updated: October 20, 2011Condition(s): Brain Cancer
- 20RecruitingLast Updated: December 19, 2011Condition(s): Recurrent or Refractory Pediatric Ependymoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+erlotinib+hydrochloride
